Brain tumors that meet the histomorphological characteristics and related pathological indicators of the World Health Organization Classification of Tumors of the Central Nervous System (WHO 2021 5th edition).
Conditions
Interventions
Sponsors
Yuebei People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years, regardless of gender; 2.Pathologically confirmed diagnosis of brain tumor, with complete histopathological sections or digital pathological image data available; 3.Received a clearly defined specific treatment modality (e.g., surgery, radiotherapy, chemoradiotherapy, or other treatment protocols specified in the study), with complete records of the treatment regimen; 4.Pretreatment MRI data meeting the study requirements (including routine sequences and specific sequences required for the study), with image quality satisfying the standards for radiomics analysis; 5.Complete clinical follow-up data available to clearly evaluate treatment response and related outcomes (including poor prognosis, functional impairment, postoperative progression, radiation necrosis, etc.);
Exclusion criteria
Exclusion criteria: 1.Prior intervention treatments (e.g., surgery or radiotherapy at other institutions) received before the current treatment, with effects that cannot be clearly delineated; 2.Comorbid severe systemic diseases or other malignant tumors that may significantly affect prognosis assessment; 3.Excessive time interval between imaging and pathological data acquisition;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment response; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative complications; | — |
Countries
China
Contacts
Public ContactLiu Xiang
Yuebei People’s Hospital
Outcome results
None listed